http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12900199

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 1491
issn 2211-3835
issueIdentifier 8
pageRange 1476-1491
publicationName Acta pharmaceutica Sinica. B
startingPage 1476
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7e6fe30a7466cd51c24817c1a546e817
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_588e0878ac9f2c201282aef6c25c1487
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c4f23048fb752cb092dceef69627df73
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a71960533e57bbfecb38e66869a95032
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cf9da13f5a3fa25f7c22526912a16ce1
bibliographicCitation Liu Z, Zhao T, Li Z, Sun K, Fu Y, Cheng T, Guo J, Yu B, Shi X, Liu H. Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors. Acta Pharmaceutica Sinica B. 2020 Aug;10(8):1476–91. doi: 10.1016/j.apsb.2019.12.008.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f267a4cbe883c6d60a8cea0a66a236d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc96eeccf0faa11b0caf69096075b002
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c25ea5c744ced1f3671a378d2686fbbb
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3a1460cf6b6677360201576c479db7b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_68b23458f488c22728a4f8db06e1c2ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1dbe67bdf19867c1a95e68f5ef445bf4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02cf3ef0887c99d855548a3e07facbd4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c59040415338930af89070d006adae54
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5d5b939e388705df43dc63aed3c39fbe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31a9bc6902f11108c0bd774e705054f2
date 202008
identifier https://doi.org/10.1016/j.apsb.2019.12.008
https://pubmed.ncbi.nlm.nih.gov/32963944
https://pubmed.ncbi.nlm.nih.gov/PMC7488365
isPartOf https://portal.issn.org/resource/ISSN/2211-3835
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41013
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8ec590477d9398bf359cbec8f1ee0348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29ed174d5a57fe84a22b65cbb2e19025
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_91bbfab87351c260d9740f8b5dae2be7
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID449209
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a2f9aadbade113e5d0983722a531b3d1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936438
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9305
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID57646
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7316

Total number of triples: 44.